左心室のエジェクション分数の軽度または重度の低下と静脈動脈不全,突然の心臓死,心不全全による死亡と保存されたエジェクション分数の関連:CHART-2研究からの報告
Tomohiro Ito1, Takashi Noda1, Kotaro Nochioka1
1Department of Cardiovascular Medicine, Tohoku University Graduate School of Medicine, Sendai, Japan.
まとめ
保存されたエジェクション分数 (HFpEF) の患者の左心室エジェクション分数 (LVEF) の低下は,致死性不律および死亡のリスクを高めます. 定期的なLVEFモニタリングは,HFpEF患者の管理に不可欠です.
科学分野:
- 心臓病科
- 心不全 の 研究
- アリズム障害に関する研究
背景:
- 左心室噴出分数 (LVEF) の低下は,保存された噴出分数 (HFpEF) の心不全において一般的です.
- 心不全 (HF) の突然心臓死リスクの評価において,ベースラインのLVEFは極めて重要です.
- HFpEFにおける致死性不律現象に対するLVEF減少の影響は不明である.
研究 の 目的:
- HFpEF患者におけるLVEF低下と致死性不律症との関連を調査する.
- 時間の経過とともにLVEFの減少がHFpEFの悪影響を予測するかどうかを判断する.
主な方法:
- CHART-2 試験のデータを遡及的に分析した.
- ベースラインでのLVEF ≥50%の1453人のHF患者を含む.
- 1年間のフォローアップでLVEFに基づいてグループに分類 (≥50%,36-50%,≤35%).
主要な成果:
- 静脈動脈不全,静脈動,急性心臓死亡の複合エンドポイントは,患者の5. 4%で発生した.
- 1年後のLVEF < 50%は,より高い複合イベント率 (11. 7% 対 4. 8%) とあらゆる原因による死亡率 (62. 8% 対 51. 8%) と関連していました.
- LVEFが50%未満に低下すると,複合イベントのリスクが増加すると独立して予測された (aHR 1. 99, P=0. 04).
結論:
- HFpEF患者におけるLVEFの軽度な低下でさえ,心室動脈不全,突然心死,全因死亡のリスクの増加と関連しています.
- 継続的な臨床評価とLVEFの再評価は,効果的なHFpEF管理に不可欠です.
- 時間の経過によるLVEFの変化は,HFpEFにおける重要な予後情報を提供します.
関連する概念動画
Pathophysiology of Heart Failure
1.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K
Heart Failure II: Pathophysiology
37
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
37
Heart Failure I: Introduction
52
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
52
Heart Failure IV: Classification and Diagnostic Evaluation
32
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
32
Imbalances in Cardiac Output
1.5K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.5K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
45
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
45


